SAMHSA analysis of Trump executive order on opioids

An important interpretation of President Trump's Oct. 5, 2020, executive order on opioids came from Elinore McCance-Katz, M.D., Ph.D., outgoing administrator of the Substance Abuse and Mental Health Services Administration (SAMHSA), on Dec. 24. The 25-page report includes recommendations — not binding — for things like expansion of buprenorphine treatment and central registries. For the report, go to https://www.samhsa.gov/sites/default/files/saving-lives-mental-behavioral-health-needs.pdf.